Delivery Order SPE2DB22D3501-SPE2DB25FUL44

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,186.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a completion date of May 8, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, valued at $2,415.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a Delivery Order under an Indefinite Delivery Contract (IDC), covers the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of December 17, 2024 and uses a Firm Fixed Price pricing type. The award was not designated under any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,333.49 firm fixed-price delivery order is for the supply of 4565286034 CORLANOR 5 MG TABLET 60S, a cardiovascular medication. The contract has a period of performance through July 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,162.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of CORLANOR 5MG 60S pharmaceutical products, valued at $10,035.49. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The IDC serves...
This federal contract award, valued at $1,959.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 21, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,093.80 firm fixed-price delivery order contract is for the supply of CORLANOR 5 MG TABLET 60S, a prescription medication. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This federal contract award, valued at $6,402.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through May 4, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award, valued at $3,266.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,235.76 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a specialty medication used for cardiovascular health. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUL44
    Delivery Order

This federal contract award, valued at $5,460.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor for this award, and there is no mention of any major subcontractors.

Generated 5/7/25, 9:56 AM